Jon M. Huibregtse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jon M. Huibregtse has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Larissa A. Durfee
Section of Molecular Genetics and Molecular Biology, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA
4 shared publicationsHyung Cheol Kim
Institute for Cellular and Molecular Biology, University of Texas, Austin, Texas, 78712, USA
2 shared publicationsMelissa L. Kelley
2 shared publicationsNancy Lyon
Section of Molecular Genetics and Microbiology, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA
2 shared publicationsYounghoon Kee
Institute for Cellular and Molecular Biology, Section of Molecular Genetics and Microbiology, University of Texas at Austin, Austin, TX 78712, USA
2 shared publicationsAlanna M Steffen
Department of Biological Sciences, Howard Hughes Medical Institute, Purdue University, West Lafayette, Indiana, 47907, USA
1 shared publication
Latest Publications
- Open Access
- 11 January 2012
- Published by Springer Nature
- Vol. 832, 141-149
The ISG15 Conjugation System
ISG15 is a ubiquitin-like modifier that is expressed in response to type 1 interferon signaling (IFN-α/β) and plays a role in antiviral responses. The core E1, E2, and E3 enzymes for ISG15 are Ube1L, UbcH8, and Herc5, respectively, and these are all also induced at the transcriptional level by IFN-α/β. We recently showed that Herc5 associates with polysomes and modifies target proteins in a cotranslational manner. Here, we describe the expression of the core conjugating enzymes in human cells, the detection of ISG15 conjugates, and the methods for fractionation of Herc5 with polysomes.
- 11 January 2012
- Published by Springer Nature
- Vol. 832, 141-149
Open AccessThe ISG15 Conjugation System
ISG15 is a ubiquitin-like modifier that is expressed in response to type 1 interferon signaling (IFN-α/β) and plays a role in antiviral responses. The core E1, E2, and E3 enzymes for ISG15 are Ube1L, UbcH8, and Herc5, respectively, and these are all also induced at the transcriptional level by IFN-α/β. We recently showed that Herc5 associates with polysomes and modifies target proteins in a cotranslational manner. Here, we describe the expression of the core conjugating enzymes in human cells, the detection of ISG15 conjugates, and the methods for fractionation of Herc5 with polysomes.
- Open Access
- 11 March 2011
- Published by Springer Nature in EMBO Reports
- Vol. 12 (4) , 334-341
Structure and function of a HECT domain ubiquitin‐binding site
The Rsp5 ubiquitin ligase contains a non‐covalent binding site for ubiquitin within the amino‐terminal lobe (N‐lobe) of the HECT domain, and the X‐ray crystal structure of the HECT–ubiquitin complex has been determined. Hydrophobic patch residues of ubiquitin (L8, I44, V70) were crucial for interaction with Rsp5, and amino‐acid alterations at the Rsp5‐binding interface resulted in defects in polyubiquitination. Our results support a model in which the N‐lobe‐binding site acts to localize and orient the distal end of the ubiquitin chain to promote conjugation of the next ubiquitin molecule.
- 11 March 2011
- Published by Springer Nature in EMBO Reports
- Vol. 12 (4) , 334-341
Open AccessStructure and function of a HECT domain ubiquitin‐binding site
The Rsp5 ubiquitin ligase contains a non‐covalent binding site for ubiquitin within the amino‐terminal lobe (N‐lobe) of the HECT domain, and the X‐ray crystal structure of the HECT–ubiquitin complex has been determined. Hydrophobic patch residues of ubiquitin (L8, I44, V70) were crucial for interaction with Rsp5, and amino‐acid alterations at the Rsp5‐binding interface resulted in defects in polyubiquitination. Our results support a model in which the N‐lobe‐binding site acts to localize and orient the distal end of the ubiquitin chain to promote conjugation of the next ubiquitin molecule.
- 1 June 2010
- Published by Elsevier in Molecular Cell
- Vol. 38 (5) , 722-732
The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15
- 1 June 2010
- Published by Elsevier in Molecular Cell
- Vol. 38 (5) , 722-732
The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15
- 1 January 2010
- Published by Springer Nature
- Vol. 54, 228-237
Identification and Validation of ISG15 Target Proteins
ISG15 is an interferon-induced ubiquitin-like protein (Ubl) that has antiviral properties. The core E1, E2 and E3 enzymes for conjugation of human ISG15 are Ube1L, UbcH8 and Herc5, all of which are induced at the transcriptional level by Type 1 interferon signaling. Several proteomics studies have, together, identified over 300 cellular proteins as ISG15 targets. These targets include a broad range of constitutively expressed proteins and approximately 15 interferon-induced proteins. This chapter provides an overview of the target identification process and the validation of these targets. We also discuss the limited number of examples where the biochemical effect of ISG15 conjugation on target proteins has been characterized.
- 1 January 2010
- Published by Springer Nature
- Vol. 54, 228-237
Identification and Validation of ISG15 Target Proteins
ISG15 is an interferon-induced ubiquitin-like protein (Ubl) that has antiviral properties. The core E1, E2 and E3 enzymes for conjugation of human ISG15 are Ube1L, UbcH8 and Herc5, all of which are induced at the transcriptional level by Type 1 interferon signaling. Several proteomics studies have, together, identified over 300 cellular proteins as ISG15 targets. These targets include a broad range of constitutively expressed proteins and approximately 15 interferon-induced proteins. This chapter provides an overview of the target identification process and the validation of these targets. We also discuss the limited number of examples where the biochemical effect of ISG15 conjugation on target proteins has been characterized.
- 1 June 2009
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 29 (12) , 3307-3318
Polyubiquitination by HECT E3s and the Determinants of Chain Type Specificity
Polyubiquitination can mediate several different biochemical functions, determined in part by which lysine of ubiquitin is used to link the polyubiquitin chain. Among the HECT domain ubiquitin ligases, some, such as human E6AP, preferentially catalyze the formation of K48-linked polyubiquitin chains, while others, including Saccharomyces cerevisiae Rsp5 and human Itch, preferentially catalyze the formation of K63-linked chains. The features of HECT E3s that determine their chain type specificities have not been identified. We show here that chain type specificity is a function solely of the Rsp5 HECT domain, that the identity of the cooperating E2 protein does not influence the chain type specificity, that single chains produced by Rsp5 contain between 12 and 30 ubiquitin moieties, and that the determinants of chain type specificity are located within the last 60 amino acids of the C lobe of the HECT domain. Our results are also consistent with a simple sequential-addition mechanism for polyubiquitination by Rsp5, rather than a mechanism involving the formation of either E2- or E3-linked polyubiquitin chain transfers.
- 1 June 2009
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 29 (12) , 3307-3318
Polyubiquitination by HECT E3s and the Determinants of Chain Type Specificity
Polyubiquitination can mediate several different biochemical functions, determined in part by which lysine of ubiquitin is used to link the polyubiquitin chain. Among the HECT domain ubiquitin ligases, some, such as human E6AP, preferentially catalyze the formation of K48-linked polyubiquitin chains, while others, including Saccharomyces cerevisiae Rsp5 and human Itch, preferentially catalyze the formation of K63-linked chains. The features of HECT E3s that determine their chain type specificities have not been identified. We show here that chain type specificity is a function solely of the Rsp5 HECT domain, that the identity of the cooperating E2 protein does not influence the chain type specificity, that single chains produced by Rsp5 contain between 12 and 30 ubiquitin moieties, and that the determinants of chain type specificity are located within the last 60 amino acids of the C lobe of the HECT domain. Our results are also consistent with a simple sequential-addition mechanism for polyubiquitination by Rsp5, rather than a mechanism involving the formation of either E2- or E3-linked polyubiquitin chain transfers.
- Open Access
- 1 August 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (35) , 23895-23902
The Basis for Selective E1-E2 Interactions in the ISG15 Conjugation System
- 1 August 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (35) , 23895-23902
Open AccessThe Basis for Selective E1-E2 Interactions in the ISG15 Conjugation System
- Open Access
- 1 January 2008
- Published by Springer Nature in BMC Biochemistry
- Vol. 9 (Suppl 1) , S4
HPV E6, E6AP and cervical cancer
Every year, approximately 470,000 new cases of cervical cancer are diagnosed and approximately 230,000 women worldwide die of the disease, with the majority (approximately 80%) of these cases and deaths occurring in developing countries. Human papillomaviruses (HPVs) are the etiological agents in nearly all cases (99.7%) of cervical cancer, and the HPV E6 protein is one of two viral oncoproteins that is expressed in virtually all HPV-positive cancers. E6 hijacks a cellular ubiquitin ligase, E6AP, resulting in the ubiquitylation and degradation of the p53 tumor suppressor, as well as several other cellular proteins. While the recent introduction of prophylactic vaccines against specific HPV types offers great promise for prevention of cervical cancer, there remains a need for therapeutics. Biochemical characterization of E6 and E6AP has suggested approaches for interfering with the activities of these proteins that could be useful for this purpose. PUBLICATION HISTORY : Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).
- 1 January 2008
- Published by Springer Nature in BMC Biochemistry
- Vol. 9 (Suppl 1) , S4
Open AccessHPV E6, E6AP and cervical cancer
Every year, approximately 470,000 new cases of cervical cancer are diagnosed and approximately 230,000 women worldwide die of the disease, with the majority (approximately 80%) of these cases and deaths occurring in developing countries. Human papillomaviruses (HPVs) are the etiological agents in nearly all cases (99.7%) of cervical cancer, and the HPV E6 protein is one of two viral oncoproteins that is expressed in virtually all HPV-positive cancers. E6 hijacks a cellular ubiquitin ligase, E6AP, resulting in the ubiquitylation and degradation of the p53 tumor suppressor, as well as several other cellular proteins. While the recent introduction of prophylactic vaccines against specific HPV types offers great promise for prevention of cervical cancer, there remains a need for therapeutics. Biochemical characterization of E6 and E6AP has suggested approaches for interfering with the activities of these proteins that could be useful for this purpose. PUBLICATION HISTORY : Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).
- 1 March 2007
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 354 (2) , 329-333
Regulation of catalytic activities of HECT ubiquitin ligases
- 1 March 2007
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 354 (2) , 329-333
Regulation of catalytic activities of HECT ubiquitin ligases
- Open Access
- 2 June 2005
- Published by Springer Nature in The EMBO Journal
- Vol. 24 (13) , 2414-2424
The Rsp5 ubiquitin ligase is coupled to and antagonized by the Ubp2 deubiquitinating enzyme
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 2 June 2005
- Published by Springer Nature in The EMBO Journal
- Vol. 24 (13) , 2414-2424
Open AccessThe Rsp5 ubiquitin ligase is coupled to and antagonized by the Ubp2 deubiquitinating enzyme
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- Open Access
- 15 March 2005
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (6) , 3737-3747
The Global Transcriptional Effects of the Human Papillomavirus E6 Protein in Cervical Carcinoma Cell Lines Are Mediated by the E6AP Ubiquitin Ligase
The function of the human papillomavirus (HPV) E6 protein that is most clearly linked to carcinogenesis is the targeted degradation of p53, which is dependent on the E6AP ubiquitin ligase. Additional functions have been attributed to E6, including the stimulation of telomerase activity and the targeted degradation of other cellular proteins, but in most cases it is unclear whether these activities are also E6AP dependent. While E6 clearly influences the transcriptional program of HPV-positive cell lines through the inactivation of p53, it has been shown that at least a subset of its p53-independent functions are also reflected in the transcriptional program. For this study, we have determined the extent to which E6AP is involved in mediating the set of E6 functions that impact on the global transcriptional program of HPV-positive cell lines. The transcriptional profiles of ∼31,000 genes were characterized for three cell lines (HeLa, Caski, and SiHa cells) after small interfering RNA (siRNA)-mediated silencing of E6 or E6AP. We found that E6 and E6AP siRNAs elicited nearly identical alterations in the transcriptional profile of each cell line. Some of the expression alterations were apparent secondary effects of p53 stabilization, while the basis of most other changes was not reconcilable with previously proposed E6 functions. While expression changes of the TERT gene (telomerase catalytic subunit) were not revealed by the array, telomerase repeat amplification protocol assays showed that both E6 and E6AP knockouts resulted in a suppression of telomerase activity. Together, these results suggest that E6AP mediates a broad spectrum of E6 functions, including virtually all functions that impact on the transcriptional program of HPV-positive cell lines.
- 15 March 2005
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (6) , 3737-3747
Open AccessThe Global Transcriptional Effects of the Human Papillomavirus E6 Protein in Cervical Carcinoma Cell Lines Are Mediated by the E6AP Ubiquitin Ligase
The function of the human papillomavirus (HPV) E6 protein that is most clearly linked to carcinogenesis is the targeted degradation of p53, which is dependent on the E6AP ubiquitin ligase. Additional functions have been attributed to E6, including the stimulation of telomerase activity and the targeted degradation of other cellular proteins, but in most cases it is unclear whether these activities are also E6AP dependent. While E6 clearly influences the transcriptional program of HPV-positive cell lines through the inactivation of p53, it has been shown that at least a subset of its p53-independent functions are also reflected in the transcriptional program. For this study, we have determined the extent to which E6AP is involved in mediating the set of E6 functions that impact on the global transcriptional program of HPV-positive cell lines. The transcriptional profiles of ∼31,000 genes were characterized for three cell lines (HeLa, Caski, and SiHa cells) after small interfering RNA (siRNA)-mediated silencing of E6 or E6AP. We found that E6 and E6AP siRNAs elicited nearly identical alterations in the transcriptional profile of each cell line. Some of the expression alterations were apparent secondary effects of p53 stabilization, while the basis of most other changes was not reconcilable with previously proposed E6 functions. While expression changes of the TERT gene (telomerase catalytic subunit) were not revealed by the array, telomerase repeat amplification protocol assays showed that both E6 and E6AP knockouts resulted in a suppression of telomerase activity. Together, these results suggest that E6AP mediates a broad spectrum of E6 functions, including virtually all functions that impact on the transcriptional program of HPV-positive cell lines.